✦ LIBER ✦
Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial
✍ Scribed by Robert Carr; Peter Brocklehurst; Caroline J Doré; Neena Modi
- Book ID
- 117304212
- Publisher
- The Lancet
- Year
- 2009
- Tongue
- English
- Weight
- 180 KB
- Volume
- 373
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.